What is the current Price Target for the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock?

The average Bio-Rad Laboratories Inc. - Ordinary Shares - Class A target price is $313.50. This is 34.89% higher than the current stock price. The highest price target is 63.93%, the lowest is 5.41%. 6 Analysts have issued a price target Bio-Rad Laboratories Inc. - Ordinary Shares - Class A 2026 .

What's going on with the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock today?

The performance of Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Forecast, price target & analysts

Q: How high will the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock rise?

No reliable answer can be given as to how high the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock will rise. The performance of stocks, including the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

Q: Why did the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock fall?

The decline in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

$232.42

0.97% yesterday

NYSE, Jun 12, 10:10 pm CET

ISIN

US0905722072

Symbol

BIO

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts Strategies

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Classifications & Recommendation:

Buy

67%

Hold

33%

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Price Target

Target Price	$313.50
Price	$232.42
Potential	34.89% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Bio-Rad Laboratories Inc. - Ordinary Shares - Class A 2026 . The average Bio-Rad Laboratories Inc. - Ordinary Shares - Class A target price is $313.50. This is 34.89% register free of charge higher than the current stock price. The highest price target is $381.00 63.93% register free of charge , the lowest is $245.00 5.41% register free of charge .
	A rating was issued by 9 analysts: 6 Analysts recommend Bio-Rad Laboratories Inc. - Ordinary Shares - Class A to buy, 3 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock has an average upside potential 2026 of 34.89% register free of charge . Most analysts recommend the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Revenue Billion $	2.57	2.52
	3.92%	2.00%
EBITDA Margin	11.78%	16.45%
	15.42%	39.61%

6 Analysts have issued a sales forecast Bio-Rad Laboratories Inc. - Ordinary Shares - Class A 2025 . The average Bio-Rad Laboratories Inc. - Ordinary Shares - Class A sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$2.6b	3.92%
2025	$2.5b 2.00% Unlock
2026	$2.6b 3.87% Unlock
2027	$2.7b 4.54% Unlock
2028	$2.9b 5.66% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
EV/Sales		2.34

Based on analysts' sales estimates for 2025, the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	2.31	22.22%
2025	2.34 1.16% Unlock
2026	2.25 3.72% Unlock
2027	2.15 4.34% Unlock
2028	2.04 5.36% Unlock

Current	2.49	20.73%
2025	2.52 1.03% Unlock
2026	2.43 3.72% Unlock
2027	2.32 4.35% Unlock
2028	2.20 5.36% Unlock

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A...

Current Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Wells Fargo	Locked ➜ Locked	Locked	Jun 09 2025
Citigroup	Locked ➜ Locked	Locked	May 02 2025
RBC Capital	Locked ➜ Locked	Locked	May 02 2025
UBS	Locked ➜ Locked	Locked	May 02 2025
Wells Fargo	Locked ➜ Locked	Locked	Apr 17 2025
Wells Fargo	Locked ➜ Locked	Locked	Feb 12 2025
RBC Capital	Locked ➜ Locked	Locked	Jan 14 2025

Analyst Rating	Date
Locked Wells Fargo: Locked ➜ Locked	Jun 09 2025
Locked Citigroup: Locked ➜ Locked	May 02 2025
Locked RBC Capital: Locked ➜ Locked	May 02 2025
Locked UBS: Locked ➜ Locked	May 02 2025
Locked Wells Fargo: Locked ➜ Locked	Apr 17 2025
Locked Wells Fargo: Locked ➜ Locked	Feb 12 2025
Locked RBC Capital: Locked ➜ Locked	Jan 14 2025

Discover more stocks with a high price target

TUI 63.33%

Alibaba Group Holding Ltd 39.18%

NIO ADR 36.92%

BioNTech SE - ADR 32.72%

MongoDB 29.30%

Adidas 27.47%

Tencent Holdings Ltd. 25.42%

Deutsche Telekom 25.28%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now